Anakinra
Sobi.ANAKIN-303
Phase 3 small_molecule active
Quick answer
Anakinra for Still's Disease, Juvenile Onset is a Phase 3 program (small_molecule) at Swedish Orphan Biovitrum AB (publ) with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Swedish Orphan Biovitrum AB (publ)
- Indication
- Still's Disease, Juvenile Onset
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active